GlassScriptPhysician profile
Marlene Flores
NPI 1659039931
$736.92
in general payments reported to CMS, 2019-2025
14 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.53 · 2023: $266 · 2024: $217 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $215.30 | 2023-2025 | Bexsero, Pediarix, Rotarix |
| Cranial Technologies, INC | $110.44 | 2023-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $87.83 | 2023-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Sanofi Pasteur INC. | $59.19 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.95 | 2025 | |
| Collegium Pharmaceutical, INC. | $46.60 | 2025 | Jornay Pm |
| Sobi, INC | $31.67 | 2023 | |
| Exact Sciences Corporation | $26.89 | 2025 | The Cologuard Plus Collection Kit |
| Seqirus USA INC | $25.54 | 2024 | Flucelvax |
| Sanofi-Aventis U.S. LLC | $22.41 | 2025 | |
| Masimo Corporation | $16.92 | 2022 | |
| Pfizer INC. | $16.74 | 2024 | |
| Alk-Abello, INC | $12.83 | 2023 | Odactra, Grastek |
| Cumberland Pharmaceuticals, INC. | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.